My first question is why is there still the statutory exemption to tobacco products?
My second question is in terms of risk management. A lot of this seems to be focused on acute exposure. How are you organizing the science when we know that for some things it's over accumulated exposure that actually there are health effects, as with BPA? We know that tissue has tons of this stuff in it, so people must be getting it somehow. How are you going to determine this?
Also, there's the science of the two or three different chemicals that may be added together in a certain way--i.e., two and two makes five, in a certain way. How do you do that? What is the advisory process that you use in obtaining the science?
Finally, this actually says “safety of consumer products”. Do you have a process within this that deals with consumers in terms of their being allowed to determine the risk that is acceptable to them or not? You would think that in consumer safety, you would be the best in all of government in consulting consumers and educating consumers as to what they see as acceptable or not, given the facts.
I guess you could start with the question on tobacco.